Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase III - Transitional Centers (P30 Clinical Trial Optional)

Grant Name
Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase III - Transitional Centers (P30 Clinical Trial Optional)
Funder
U.S. Department of Health and Human Services
Country or Region
United States
Research Field
Medicine, General Medicine
Biochemistry, Genetics and Molecular Biology, General Biochemistry,Genetics and Molecular Biology
Deadline
May 27, 2022 (Expired)
Grant Size
Up to 750,000 USD
Contact Info
Gao,Hongwei hongwei.gao@nih.gov
Grant Number
PAR-20-115
Description
The purpose of this Funding Opportunity Announcement (FOA) is to transition the core resources and biomedical research activities of Centers of Biomedical Research Excellence (COBRE) into independence and sustainability.

Funding resources

Purdue Grant Writing Lab: Introduction to Grant Writing Open Link
University of Wisconsin Writing Center: Planning and Writing a Grant Proposal Open Link

Quick share


Add deadline to calendar

May 27, 2022

Have a funding opportunity that you want to list here?

Submit the grant details to support@peeref.com for review and listing.


Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Related opportunities

International Research Ethics Education and Curriculum Development Award (R25 Clinical Trial Not Allowed)
Health Jun 06, 2024 12:00:00 AM EDT $230,000
Northern Territory Pathways to Community Control
Indigenous Health 30-Jun-2024 $8,750,000.00
NIOSH Centers for Agricultural Safety and Health
Health Dec 01, 2024 12:00:00 AM EST $2,200,000
Tribal Behavioral Health
Health May 15, 2025 12:00:00 AM EDT $250,000
Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional)
Health May 28, 2025 12:00:00 AM EDT $1,500,000
Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed)
Health Sep 05, 2025 12:00:00 AM EDT $300,000
Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)
Health Sep 05, 2025 12:00:00 AM EDT $1,838,436
MOMENTUM (Moving Integrated, Quality Maternal, Newborn, and Child Health and Family Planning and Reproductive Health Services to Scale)
Medicine September 30, 2025 Up to 25,000,000 USD
MOMENTUM (Moving integrated, quality Maternal, Newborn, and Child Health and Family Planning and Reproductive Health services to scale): Targeted MNCH/FP/RH technical assistance to private providers
Medicine September 30, 2025 Up to 75,000,000 USD
MRFF 2022 Frontier Health and Medical Research Grant Opportunity
Health and Medical Research 31-Mar-2026 $400,000,000.00